{"id":"https://openalex.org/W4361249397","doi":"https://doi.org/10.1158/0008-5472.c.6495551.v1","title":"Data from Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells","display_name":"Data from Spontaneous Mammary Tumors Differ Widely in Their Inherent Sensitivity to Adoptively Transferred T Cells","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361249397","doi":"https://doi.org/10.1158/0008-5472.c.6495551.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6495551.v1","doi":"https://doi.org/10.1158/0008-5472.c.6495551.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6495551.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6495551.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067583313","display_name":"Erika M. Wall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika M. Wall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066165449","display_name":"Katy Milne","orcid":"https://orcid.org/0000-0001-5616-1821","observed_orcids":["https://orcid.org/0000-0001-5616-1821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katy Milne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013750857","display_name":"Michele L. Martin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele L. Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019623844","display_name":"Peter Hamilton Watson","orcid":"https://orcid.org/0000-0002-1642-0638","observed_orcids":["https://orcid.org/0000-0002-1642-0638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter H. Watson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023237336","display_name":"Patty M. Theiss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patty Theiss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058837420","display_name":"Brad H. Nelson","orcid":"https://orcid.org/0000-0002-4445-5539","observed_orcids":["https://orcid.org/0000-0002-4445-5539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brad H. Nelson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.025299999862909317,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spontaneous-mammary-tumors","display_name":"spontaneous mammary tumors","score":0.902999997138977},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.7919999957084656},{"id":"https://openalex.org/keywords/her2-neu-oncogene","display_name":"HER2/neu oncogene","score":0.9459999799728394},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.5870000123977661},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.5239999890327454},{"id":"https://openalex.org/keywords/mhc-class-i-expression","display_name":"MHC class I expression","score":0.8690000176429749},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.671999990940094},{"id":"https://openalex.org/keywords/tumor-microenvironment-heterogeneity","display_name":"tumor microenvironment heterogeneity","score":0.7049999833106995},{"id":"https://openalex.org/keywords/transgenic-t-cells","display_name":"transgenic T cells","score":0.5529999732971191},{"id":"https://openalex.org/keywords/mammary-adenocarcinoma","display_name":"mammary adenocarcinoma","score":0.7850000262260437},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5199999809265137}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5784693360328674},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4752877950668335},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.4368172287940979},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.43537819385528564},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41361939907073975},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.411428838968277},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4099177420139313},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4031424820423126},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3886246085166931},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3633110821247101},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35647332668304443},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29352056980133057},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27151060104370117},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.1361558437347412}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6495551.v1","doi":"https://doi.org/10.1158/0008-5472.c.6495551.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6495551.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6495551.v1","doi":"https://doi.org/10.1158/0008-5472.c.6495551.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6495551.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2142483688","https://openalex.org/W2750783852","https://openalex.org/W2907571060","https://openalex.org/W1621615533","https://openalex.org/W2491826241","https://openalex.org/W2086404897","https://openalex.org/W2083972800","https://openalex.org/W2046485878","https://openalex.org/W4361238748","https://openalex.org/W2331198396"],"abstract_inverted_index":{"Abstract":[0],"Immunotherapy":[1],"of":[2,9,67,92,94,140,173,193,206],"cancer":[3],"can":[4,168],"lead":[5],"to":[6,17,41,64,157],"the":[7,34,89,186,191,204,207],"selection":[8],"antigen":[10],"loss":[11],"variants,":[12],"which":[13],"provides":[14],"strong":[15],"rationale":[16],"target":[18],"oncogenes":[19],"that":[20,127,200],"are":[21],"essential":[22,166],"for":[23],"tumor":[24,208],"growth":[25],"or":[26,75,102],"viability.":[27],"To":[28,189],"investigate":[29],"this":[30],"concept,":[31],"we":[32],"tagged":[33],"HER2/neu":[35],"oncogene":[36,167],"with":[37,115],"epitopes":[38],"from":[39],"ovalbumin":[40],"confer":[42],"recognition":[43],"by":[44,88],"T-cell":[45,158],"receptor":[46],"transgenic":[47],"CD8+":[48],"(OT-I)":[49],"and":[50,121,145,149],"CD4+":[51],"(OT-II)":[52],"T":[53,161],"cells.":[54],"Transgenic":[55],"mice":[56,114],"expressing":[57],"neuOT-I/OT-II":[58],"developed":[59],"mammary":[60,176],"adenocarcinomas":[61],"at":[62,131],"6":[63],"10":[65],"months":[66],"age.":[68],"Adoptively":[69],"transferred":[70],"naive":[71],"OT-I":[72],"cells":[73,162],"(with":[74],"without":[76],"OT-II":[77],"cells)":[78],"proliferated":[79],"vigorously":[80],"on":[81],"encountering":[82],"neuOT-I/OT-II-expressing":[83],"tumors.":[84,177],"This":[85],"was":[86],"followed":[87],"complete":[90,109],"regression":[91,110],"37%":[93],"tumors,":[95,118,181],"whereas":[96],"others":[97],"showed":[98],"partial/stable":[99],"responses":[100],"(40%)":[101],"progressive":[103],"disease":[104],"(23%).":[105],"Those":[106],"tumors":[107,142],"undergoing":[108],"never":[111],"recurred.":[112],"In":[113],"multiple":[116],"primary":[117],"simultaneous":[119],"regressions":[120],"nonregressions":[122],"were":[123],"often":[124],"seen,":[125],"indicating":[126],"immune":[128],"evasion":[129],"occurred":[130],"a":[132,154,171],"local":[133,182],"rather":[134],"than":[135],"systemic":[136],"level.":[137],"The":[138],"majority":[139],"nonregressing":[141],"expressed":[143],"NeuOT-I/OT-II":[144],"MHC":[146],"class":[147],"I,":[148],"many":[150],"avoided":[151],"rejection":[152],"through":[153],"profound":[155],"block":[156],"infiltration.":[159],"Thus,":[160],"directed":[163],"against":[164,195],"an":[165],"permanently":[169],"eradicate":[170],"subset":[172],"spontaneous,":[174],"established":[175],"However,":[178],"in":[179],"other":[180],"barriers":[183],"severely":[184],"limit":[185],"therapeutic":[187],"response.":[188],"maximize":[190],"efficacy":[192],"immunotherapy":[194],"spontaneous":[196],"cancers,":[197],"predictive":[198],"strategies":[199],"take":[201],"into":[202],"account":[203],"heterogeneity":[205],"microenvironment":[209],"will":[210],"be":[211],"required.":[212],"[Cancer":[213],"Res":[214],"2007;67(13):6442\u201350]":[215]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2023-03-31T00:00:00"}